Moreover, we found that Ang II treatment could significantly enhance VSMC migration and proliferation, and treatment with FOS notably reduced Ang II-induced phenotypic transformation, migration, and proliferation of VSMCs, validating the efficacy of the Ang II-induced hypertension in vitro model. The gene discussed is FOS; the disease is Hypertension.